05/08/2024
6:18 PM | Acasti Pharma (Issuer)
Kohli Prashant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:18 PM | Acasti Pharma (Issuer)
DelAversano Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:19 PM | Acasti Pharma (Issuer)
Macdonald R. Loch (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:19 PM | Acasti Pharma (Issuer)
Kumar Amresh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:19 PM | Acasti Pharma (Issuer)
D'Andrea Carrie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
7:46 AM | Acasti Pharma (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
04/01/2024
7:00 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/13/2024
6:03 PM | Acasti Pharma (Subject)
BANK OF AMERICA CORP /DE/ (Filed by)
| Form SC 13G | |
02/12/2024
7:00 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
6:30 AM | Acasti Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
01/08/2024
7:00 AM | Acasti Pharma (Issuer)
DelAversano Robert J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2024
6:30 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
6:30 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
7:10 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:30 AM | Acasti Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2023
3:30 PM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
11:21 AM | Acasti Pharma (Issuer)
DAVIS A BRIAN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/20/2023
11:22 AM | Acasti Pharma (Issuer)
NEUGEBOREN EDWARD (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/20/2023
11:23 AM | Acasti Pharma (Issuer)
Kottayil George (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2023
11:15 PM | Acasti Pharma (Filer)
| Form EFFECT | |
10/16/2023
3:31 PM | Acasti Pharma (Filer)
| Form 424B3 | |
10/11/2023
3:30 PM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
6:40 AM | Acasti Pharma (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/06/2023
3:30 PM | Acasti Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/27/2023
6:46 PM | Acasti Pharma (Issuer)
Kavuru Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2023
7:10 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/25/2023
4:01 PM | Acasti Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/25/2023
3:15 PM | Acasti Pharma (Filer)
| Form DEF 14A | |
08/25/2023
3:21 PM | Acasti Pharma (Filer)
| Form DEFA14A | |
08/11/2023
6:31 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
6:15 AM | Acasti Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2023
4:30 PM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
3:32 PM | Acasti Pharma (Issuer)
D'Andrea Carrie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:34 PM | Acasti Pharma (Issuer)
Macdonald R. Loch (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:36 PM | Acasti Pharma (Issuer)
Olds Donald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:36 PM | Acasti Pharma (Issuer)
Kavuru Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:37 PM | Acasti Pharma (Issuer)
Derby Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:26 PM | Acasti Pharma (Issuer)
Kohli Prashant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:28 PM | Acasti Pharma (Issuer)
Kumar Amresh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
7:30 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
6:31 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
This indicator is great for calling bottoms (Ad) “It was designed to help boost your chances of finding rock solid trade ideas”
It’s called the “Master Indicator”
And it’s quite possibly one of the most useful indicators you’ll ever use. If you’d like to join me just follow this link here. |
06/23/2023
6:01 AM | Acasti Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
